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Abstract
We systematically reviewed and meta-analyzed the effects of acute exercise-condi-
tioned serum on cancer cell growth in vitro. Five literature databases were systemati-
cally searched for studies that measured cancer cell growth after exposure to human 
sera obtained before and immediately after an acute bout of exercise. Standardized 
mean differences (SMDs) with 95% confidence intervals (CIs) were pooled using a 
three-level random-effects model. Meta-regressions were also performed with par-
ticipant age and disease status, exercise type, cell line TP53 status, and serum incuba-
tion time entered as covariates. Seven studies met the inclusion criteria encompassing 
a total of 21 effect estimates and 98 participants. Exercise-conditioned serum signifi-
cantly reduced cancer cell growth compared with preexercise serum (SMD = −1.23, 
95% CI: −1.96 to −0.50; p = .002; I2 = 75.1%). The weighted mean reduction as a 
percentage of preexercise values was 8.6%. The overall treatment effect and magni-
tude of heterogeneity were not statistically influenced by any covariate. There were 
concerns regarding the risk of bias within individual studies and Egger's test of the 
intercept showed evidence of small study effects (β = −3.6, p = .004). These findings 
provide in vitro evidence that the transient serological responses to acute exercises 
reduce cancer cell growth, although many questions remain regarding the underlying 
mechanistic pathways and potential effect modifiers. To strengthen this evidence-
base, future studies should seek to reduce the risk of bias by using more rigorous 
experimental designs, and consider using 3D cell culture models to better replicate in 
vivo tumor conditions. PROSPERO registration: CRD42020161333.
K E Y W O R D S
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1 |  INTRODUCTION
There is a growing body of observational research linking 
physical activity with cancer prevention. Indeed, strong 
epidemiological evidence shows that regular physical ac-
tivity reduces the risk of developing several cancer types 
including colon, postmenopasual breast, and endome-
trial (Physical Activity Guidelines Advisory Committee 
Scientific Report,  2018; World Cancer Research Fund/
American Institute for Cancer Research, 2018a). Physical 
activity after a cancer diagnosis is also associated with 
reduced risk of cancer recurrence and mortality in colon, 
breast, and prostate cancer (Cormie et  al.,  2017; Patel 
et al., 2019). This body of evidence has given rise to can-
cer-specific physical activity guidelines, with the World 
Cancer Research Fund/American Institute for Cancer 
Research (2018b) recommending that individuals en-
gage in at least 150  min  wk−1 of moderate-intensity or 
75 min wk−1 of vigorous-intensity aerobic physical activ-
ity to reduce cancer risk (World Cancer Research Fund/
American Institute for Cancer Research, 2018b).
The risk-reducing effect of physical activity is mainly 
thought to occur through changes in circulating biomark-
ers related to cancer risk, including modulations in en-
dogenous insulin, inflammatory mediators, sex hormones, 
adipokines, and insulin-like growth factor 1 (IGF-1) 
(Friedenreich et  al.,  2017; McTiernan,  2008). However, 
intervention studies show that these changes are largely 
dependent on reductions in body fat (Batacan et al., 2017; 
Dethlefsen, Pedersen, et al., 2017; Grieco et al., 2013; Kang 
et al., 2017; McTiernan, 2008; Sturgeon et al., 2016). Even 
so, most inverse associations between physical activity 
and cancer risk reported in the epidemiological literature 
remain statistically significant even after adjustment for 
body mass index (BMI) (Moore et al., 2016). Furthermore, 
a recent Mendelian randomization study using UK Biobank 
data showed that physical activity is inversely related to 
breast and colon cancer risk, independent of adiposity 
(Papadimitriou et  al.,  2020). This suggests that the anti-
neoplastic effects of exercise are explained, at least in part, 
by biological pathways other than weight loss-induced 
changes (indicative of reduced body fatness) in resting sys-
temic risk factors.
Aside from the chronic adaptations that occur in response 
to regular physical activity, each bout of exercise results 
in marked yet short-lasting alterations in many circulating 
serum factors. Acute serological responses to exercise in-
clude the release of catecholamines, anti-inflammatory cy-
tokines and myokines. (Petersen & Pedersen, 2005; Zouhal 
et  al.,  2008). Recent review papers have proposed that 
these repetitive acute serological responses could culminate 
over time to reduce cancer risk (Christensen et  al.,  2018; 
Dethlefsen, Pedersen, et  al.,  2017; Hojman et  al.,  2018), 
which has important implications for exercise prescription in 
this context. The experimental model used to evaluate this 
theory involves stimulating a cancer cell line with serum col-
lected before and after an acute bout of exercise. However, to 
date, no study has systematically synthesized nor critically 
appraised the original research studies that have explored the 
impact of acute exercise on cancer cell growth. Therefore, 
the purpose of this study was to systematically review and 
meta-analyze the effects of acute exercise-conditioned serum 
on cancer cell growth in vitro.
2 |  METHODS
This review was prospectively registered in the 
PROSPERO prospective register of systematic reviews (ref: 
CRD42020161333) and followed the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) 
guidelines (Shamseer et al., 2015).
2.1 | Search strategy
An electronic search of PubMed, Web of Science, Scopus, 
SportDiscus, and CINAHL was conducted from inception to 
3rd July 2020. The specific search terms we used are pre-
sented in Table 1. We also manually screened the reference 
lists and performed forward citation of included studies to 
identify potentially eligible studies.
2.2 | Inclusion criteria
Inclusion criteria were: (a) original research articles published in 
a peer-reviewed journal, (b) full-text was available in English, 
(c) sera were obtained from human participants before and im-
mediately after (≤5 min) an acute bout of exercise, (d) pre and 
T A B L E  1  Search terms used in PubMed
[All fields] Cancer OR neoplas* OR malignan* OR carcinoma OR 
tumor OR tumour
AND
[All fields] Exercise OR "physical activity" OR aerobic OR 
anaerobic OR "resistance training" OR “strength training” OR 
“weight training”
AND
[All fields] Cells OR “cell line*” OR “in vitro”
AND
[All fields] Serum OR sera
AND
[All fields] Growth OR proliferation OR “viability” OR “cell 
number”
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postexercise sera were used to stimulate an established human 
cancer cell line, (e) serum-stimulated cancer cell growth was 
measured after a period of incubation, and (f) reported data were 
sufficient to include in a meta-analysis. We defined exercise as a 
planned, structured activity requiring physical effort, carried out 
to sustain or improve health and fitness.
2.3 | Outcome measure
The primary outcome was cancer cell growth, which in-
volved the use of cell viability or proliferation assay. Where 
studies used more than one cancer cell line, all relevant data 
were extracted and included in the meta-analysis.
2.4 | Study selection
Once all literature searches were complete, studies 
were compiled into a single list in an Excel spreadsheet 
(Microsoft Corporation). One author (STO) removed du-
plicates and screened the titles and abstracts to identify po-
tentially relevant trials. Full-texts were then obtained for 
all studies that appeared to meet the inclusion criteria or 
F I G U R E  1  Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the systematic search and 
included studies
Records identified through 
database searching (n = 791)
● PubMed (n = 164)
● SCOPUS (n = 245)
● Web of Science (n = 294)
● SPORTDiscus (n = 14)
● CINAHL (n = 74)
Additional records identified 
through other sources
(n = 2)
Records after duplicates removed
(n = 542)
Records screened
(n = 542)
Records excluded based on 
title or abstract (n = 453)
Full-text articles 
assessed for eligibility
(n = 89)
Full-text articles excluded
(n = 82)
● Did not involve human participants
(n = 9)
● Did not involve acute bout of 
exercise (n = 8)
● Serum was not obtained before and 
immediately after exercise (n = 49)
● A cancer cell line was not 
stimulated with human sera (n = 15)
● Review article (n = 1)
Articles included in 
qualitative synthesis
(n = 7)
Articles included in 
quantitative synthesis 
(n = 7)
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T A B L E  2  Description of included studies
Author Participants Age (years) Exercise characteristics Cancer type (cell line) Serum markers Signaling pathwaysa Incubation time (hrs)
Cell growth 
measurement
Baldelli et al. (2020) Healthy, sedentary males (n = 18) and 
females (n = 12)
M: 21 ± 1
F: 21 ± 1
High-intensity aerobic interval exercise on a 
cycle ergometer
- 2 min warm-up
- 20 min @ 50%–70% WRmax
- 10 × 90 s @ 90% WRmax separated by 
3 min @ 55% WRmax
Breast (MDA-MB-231) 
and prostate (LNCaP)
↑ CK ↔ p-YAP
↔ p-GSK3β
48 Haemocytometer
Devin et al. (2019) Male colorectal cancer survivors 
(n = 10)
64 ± 6 High-intensity aerobic interval exercise on a 
cycle ergometer
- 10 min warm-up @ 50%–70% HRmax
- 4 × 4 min @ 85%–95% HRmax separated 
by 3 min active recovery
Colon (CaCo-2, LoVo) ↑ IL-6
↑ IL-8
↑ TNF-α
↑ Insulin
? IGF-1
? Glucose
- 24, 48, and 72 Fluorescence via the 
Alamar Blue assay
De Santi et al. (2019) Healthy, sedentary, premenopausal 
women (n = 3)
43 ± 10 Aerobic exercise on a treadmill
- 20 min @ 42% HRR
- 45 min @ 60% HRR
Breast (MDA-MB-231) - - 72 Fluorescence via the 
CellTiter 96 Aqueous 
Nonradioactive Cell 
Proliferation assay
Dethlefsen et al. (2016) Female breast cancer survivors 
receiving adjuvant chemotherapy 
(n = 20)
50 ± 7 Resistance training and high-intensity 
aerobic interval exercise
- 30 min dynamic warm-up combined with 
balance training
- 45 min resistance training consisting 
of three sets of 5–8 repetitions of six 
resistance exercises performed @ 
70%–100% 1RM
- 15 min aerobic interval training on a cycle 
ergometer @ 85%–95% HRmax
Breast (MCF-7, 
MDA-MB-231)
↑ IL-6
↑ IL-8
↔ IL-10
↑ TNF-α
↑ EPI
↑ NEPI
↑ Lactate
↔ Insulin
- 48 Fluorescence via the 
CellTiter-Fluor assay
Dethlefsen et al. (2017) Healthy women aged 18–30 years 
(n = 7)
25 ± 1 Aerobic exercise on a cycle ergometer
- 120 min @ 55% VO2peak
Breast (MCF-7, 
MDA-MB-231)
↑ IL-6
↑ EPI
↔ N-EPI
↑ Lactate
↑ p-YAP (MCF-7 only)
↔ t-YAP
↔ t-TAZ
48 Fluorescence via the 
CellTiter-Fluor assay
Hwang et al. (2020) Young (n = 12) and older (n = 10) 
males
Y: 28 ± 3
O: 63 ± 7
Aerobic exercise on a cycle ergometer
- 20 min @ 50% VO2max
- 40 min @ 65% VO2max
Prostate (LNCaP, PC3) ↑ ON
↑ OSM
↔ IL-6
↔ IL-15
↑Test (Y only)
- 96 Fluorescence via the 
Alamar Blue assay
Kurgan et al. (2017) Male, recreationally active University 
students (n = 6)
22 ± 2 High-intensity aerobic interval exercise on a 
cycle ergometer
- 4 min warm-up
- 6 × 1 min @ WRmax, separated by 1 min 
active recovery
Lung (A549) ↔ Insulin ↓ p-AKT
↓ p-mTOR
↓ p-S6K1
↓ p-ERK1/2
↔ t-AKT
↔ t-mTOR
↔ t-S6K1
↔ t-ERK1/2
72 Absorbance via the Crystal 
Violet Staining assay
Abbreviations: ?, not reported; ↑, statistically significant increase from pre to postexercise; ↔, no evidence of an effect; AKT, Protein Kinase B;  
CK, creatine kinase; EPI, epinephrine; ERK1/2, extracellular signal-regulated kinase 1/2; F, females; GSK3β, glycogen synthase kinase 3 beta; HRmax, age-predicted  
maximum heart rate; HRR, age-predicted heart rate reserve; IL, interleukin; M, males; mTOR, mammalian target of rapamycin; N-EPI, norepinephrine; O, older;  
ON, osteonectin; OSM, oncostatin M; p, phosphorylated; S6K1, ribosomal protein S6 kinase beta-1; t, total; TAZ, transcriptional coactivator with PDZ-binding motif;  
Test, testosterone; TNF-α, tumor necrosis factor-alpha; VO2max, maximal oxygen consumption; VO2peak, peak oxygen consumption; WRmax, maximum work rate;  
Y, young; YAP, Yes-associated protein.
aThe evaluation of signaling pathways in Dethlefsen, et al. (2017) was performed with serum obtained from breast cancer survivors in the previous study from the  
same group Dethlefsen et al. (2016). 
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where there was any uncertainty. Subsequently, two au-
thors (STO, ARJ) independently examined each full-text 
manuscript to assess for eligibility. Any disagreements 
were resolved through discussion and/or consultation with 
the third author (JMS). Corresponding authors were con-
tacted if a full-text manuscript could not be retrieved or to 
clarify aspects of the study.
2.5 | Data extraction
Data items extracted from each eligible study included: (a) 
participant characteristics, (b) sample size, (c) characteristics 
of the acute exercise bout, (d) type of cancer studied, (e) de-
tails of the cell growth assay, (f) details of the serum mark-
ers and signaling pathways evaluated, and (g) cell growth data 
(mean ± SD). Study authors were contacted to obtain missing 
data wherever necessary. If data were only presented graphi-
cally and we did not receive a response from study authors, 
we used a web-based digitizing tool to extract the data from 
graphs (WebPlotDigitizer) (Drevon et  al.,  2017). Where the 
same study data were reported in multiple manuscripts, the 
data were only extracted from the manuscript with the earliest 
publication date. All data were extracted independently by two 
authors (STO, ARJ) and tabulated in custom-designed Excel 
spreadsheets. Review authors cross-checked coding sheets and 
resolved any discrepancies with discussion and consensus.
2.6 | Risk of bias
The risk of bias within individual studies was assessed 
with the modified Research Triangle Institute (RTI) 
Item Bank for cross-sectional studies (Viswanathan & 
Berkman,  2012). The original item bank consists of 29 
items covering eleven different domains: sample definition 
and selection, interventions/exposure, outcomes, creation 
of treatment groups, blinding, soundness of information, 
follow-up, analysis comparability, analysis outcome, in-
terpretation, and presentation and reporting. In line with 
the authors’ instructions (Viswanathan & Berkman, 2012), 
we removed questions that were not applicable to this re-
view, which left a total of 14 items. For each item in a 
selected study, a positive response indicated a low risk 
of bias, a negative response indicated a high risk of bias, 
and an unclear risk of bias was given if a “partially” or 
“cannot be determined” response was observed (Margulis 
et al., 2014). Two authors (STO, ARJ) independently ap-
praised each study and resolved discrepancies via discus-
sion with the third author (JMS). Small study effects were 
explored with a funnel plot and Egger's test of the intercept 
(Egger et al., 1997).
2.7 | Statistical analysis
To quantify the effect of serum-stimulated cancer cell 
growth, standardized mean differences (SMDs) between 
postexercise and preexercise serum were calculated as the 
mean difference divided by the SD of the difference (SDdiff). 
Hedges g correction was applied to adjust for sample bias. 
Qualitative descriptors used to interpret the strength of the 
SMDs were based on Cohen's (1988) criteria (±): trivial (< 
0.2), small (0.2–0.49), moderate (0.5–0.79), large (≥0.8). 
Negative SMDs represent an exercise-induced reduction in 
cell growth.
F I G U R E  2  Funnel plot of the 
standardized mean differences from 
individual studies against the corresponding 
sampling variances
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If a study did not report SDdiff, and it could not be retrieved from 
the corresponding author, it was estimated using the SDs in cell vi-
ability at preexercise (SDpre) and postexercise (SDpost), in addition 
to the correlation (r) between measures (Higgins et al., 2019):
We followed guidelines by Rosenthal (1993) to assume 
a conservative correlation of 0.7. Sensitivity analyses were 
performed with r = .5 and r = .9 to determine whether the 
results were robust to the use of imputed correlations.
A meta-analysis of SMDs was performed using a ran-
dom-effects model with a three-level structure. SMDs were SDdiff =
√
SD
2
pre
+SD
2
post
− (2×r×SDpre×SDpost)
F I G U R E  3  Risk of Bias plot 
illustrating the proportion of included 
studies with each bias rating (low, high, or 
unclear risk) for each item in the RTI Bank 
Tool
F I G U R E  4  Forest plot of the results from a three-level random-effects meta-analysis on the effects of exercise-conditioned serum on cancer 
cell growth. Data are presented as standardized mean differences (SMDs) between pre and postexercise timepoints with corresponding 95% 
confidence intervals (CIs)
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nested within studies to account for correlated effects within 
studies (Van den Noortgate et  al., 2013). A random-effects 
model was chosen because it was assumed that due to meth-
odological differences (e.g., cancer cell line used), studies 
were estimating different, yet related effects (Borenstein 
et al., 2010). The model was fitted with the maximum like-
lihood estimation and studies were weighted according to 
the inverse of the sampling variance. Confidence intervals 
(CIs) were adjusted using the Knapp–Hartung adjustment 
due to the low number of studies (IntHout et al., 2014). The 
weighted mean difference as a percentage of preexercise val-
ues was also calculated.
The magnitude of heterogeneity not attributable to sam-
pling error was using evaluated with I2. Thresholds of I2 
were in line with Cochrane recommendations: 0%–40% 
(“might not be important”), 30%–60% (“may represent 
moderate heterogeneity”), 50%–90% (“may represent sub-
stantial heterogeneity”), and 75%–100% (“considerable het-
erogeneity”) (Deeks et al., 2019). The importance of the I2 
value was interpreted alongside the p value from the Chi-
squared test (Deeks et al., 2019). Sources of heterogeneity 
were explored using random-effects meta-regressions with 
the mean age of participants (continuous variable), type of 
aerobic exercise (interval vs. continuous exercise), cancer 
type (breast vs. other cancer), disease status of participants 
(cancer survivor vs. apparently healthy), TP53 gene status 
of the cancer cell line (mutated vs. wild type), and serum 
incubation time (≥72 hr vs. ≤48 hr) entered into the model 
as covariates. We chose to explore the potential moderating 
effect of TP53 status because somatic mutation to the TP53 
gene is the most common mutation across all cancers and 
TP53 status is well characterized among cancer cell lines 
(Leroy et al., 2014).
Statistical analyses were conducted in R version 3.5.2 
(R Foundation for Statistical Computing). Statistical signif-
icance was set at p < .05. Data are presented as SMD with 
corresponding 95% CIs. The search results, dataset, and 
statistical code are available on Open Science Framework 
(XXXX, 2020).
3 |  RESULTS
3.1 | Study selection
The primary search yielded a total of 791 abstracts, of 
which 249 were duplicates (Figure 1). After screening the 
titles and abstracts, a further 453 abstracts were removed 
and 89 full-texts were then retrieved and assessed for eli-
gibility. Seven manuscripts involving a total of 98 partici-
pants met the inclusion criteria and were included in this 
review and meta-analysis. The median sample size was 10 
(range: 3–20).
3.2 | Study and exercise characteristics
The included studies involved breast (MDA-MB-231, 
MCF-7) (Baldelli et  al.,  2020; De Santi et  al.,  2019; 
Dethlefsen, Hansen, et  al.,  2017; Dethlefsen et  al.,  2016) 
colon (CaCo-2, LoVo) (Devin et  al.,  2019), lung (A549) 
(Kurgan et al., 2017), and prostate (LNCaP, PC3) (Baldelli 
et al., 2020; Hwang et al., 2020) cancer cell lines (Table 2). 
Cell lines differed with respect to their mutation sta-
tus of cancer critical genes including TP53, KRAS, and 
BRAF. Two studies recruited cancer survivors (Dethlefsen 
et  al.,  2016; Devin et  al.,  2019) whereas the other five 
studies recruited apparently healthy adults (Baldelli 
et  al.,  2020; De Santi et  al.,  2019; Dethlefsen, Hansen, 
et al., 2017; Hwang et al., 2020; Kurgan et al., 2017). All 
studies involved aerobic exercise; four studies involved 
high-intensity aerobic interval exercise on a cycle er-
gometer, (Baldelli et  al.,  2020; Dethlefsen et  al.,  2016; 
Devin et  al.,  2019; Kurgan et  al.,  2017) and the remain-
ing three studies involved continuous aerobic exercise on a 
cycle ergometer (Dethlefsen, Hansen, et al., 2017; Hwang 
et al., 2020) or treadmill (De Santi et al., 2019). One study 
T A B L E  3  Meta-regression results
Covariate
Coefficient 
(95% CI)
p 
value
I2 (χ2 p 
value)
Age −0.01 (−0.03 to 
0.01)
0.37 79.0% 
(<0.001)
Cancer type
Breast 0.08 (−0.88 to 
1.0)
0.87 74.9% 
(<0.001)
Other — — —
Aerobic exercise type
Interval exercise −0.82 (−2.2 to 
0.53)
0.22 70.7% 
(<0.001)
Continuous exercise — — —
Disease status
Cancer survivor 0.75 (−0.70 to 
2.2)
0.29 71.9% 
(<0.001)
Apparently healthy — — —
TP53 gene status
Mutated 0.05 (−0.42 to 
0.51)
0.83 75.0% 
(<0.001)
Wild type — — —
Incubation time
≤48 hr 0.28 (−0.48 to 
1.0)
0.44 73.8% 
(<0.001)
>48 hr
Abbreviations: 95% CI, 95% confidence interval; χ2, Chi-squared test.
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also combined aerobic exercise with resistance training 
(Dethlefsen et al., 2016).
3.3 | Heterogeneity and risk of bias
The total amount of heterogeneity was considerable 
(I2 = 75.1%, p < .001). Visual inspection of the funnel plot 
showed some asymmetry (Figure 2), and Egger's test of the 
intercept was statistically significant (β  =  −3.6, 95% CI: 
−5.9 to −1.3; p = .004).
The risk of bias within individual studies is summarized 
in Figure 3 and described in detail elsewhere (XXXX, 2020). 
No studies performed an a priori sample size estimation. 
Only one study (partially) blinded outcome assessors (Devin 
et al., 2019), fidelity to the exercise protocol was unclear in 
five out of the seven studies (Baldelli et al., 2020; De Santi 
et  al.,  2019; Dethlefsen et  al.,  2016; Hwang et  al.,  2020; 
Kurgan et al., 2017) and only four studies were considered to 
adequately control for potentially confounding variables such 
as diet and physical activity prior to the experimental ses-
sion (Baldelli et al., 2020; Dethlefsen, Hansen, et al., 2017; 
Hwang et al., 2020; Kurgan et al., 2017).
3.4 | Meta-analysis results
The meta-analysis comprised of 21 effect estimates from 
seven studies (Figure 4). Exercise-conditioned serum signifi-
cantly reduced cancer cell growth compared with preexercise 
serum (SMD = −1.23, 95% CI: −1.96 to −0.50; p = .002). 
The weighted mean reduction as a percentage of preexercise 
values was 8.6%.
3.5 | Sensitivity analyses
The SDdiff was unavailable for extraction from three stud-
ies (Dethlefsen, Hansen, et al., 2017; Dethlefsen et al., 2016; 
Kurgan et al., 2017). Sensitivity analyses showed that estimat-
ing the SDdiff assuming r = 0.5 (SMD = −1.12, 95% CI: −1.85 
to −0.41; p = .004; I2 = 74.8%) or r = 0.9 (SMD = −1.49, 
95% CI: −2.30 to −0.69; p =  .001; I2 = 79.8%) instead of 
r = .7 did not change the conclusions of the meta-analysis.
3.6 | Meta-regressions
Inclusion of study characteristics as covariates in the meta-
analysis model had a negligible influence on the magnitude 
of heterogeneity and did not change the outcome in such a 
way that the 95% CI of the SMD crossed the line of no effect 
(Table 3).
4 |  DISCUSSION
The results of our systematic review and meta-analysis show 
that exercise-conditioned serum reduces in vitro cancer cell 
growth. This finding provides preliminary evidence that the 
serological responses to acute bouts of exercise may, at least 
in part, explain the link between regular physical activity and 
reduced cancer risk.
Based on the pooled data from seven studies, stimulat-
ing cancer cell lines with serum obtained immediately after a 
bout of exercise reduced cell growth by 8.6% compared with 
preexercise serum. This finding provides preliminary cor-
roboration for the theory that repetitive spikes in circulating 
factors in response to acute bouts of exercise could culminate 
over time to reduce cancer risk and tumor growth (Dethlefsen, 
Pedersen, et al., 2017). The modest magnitude of the growth 
inhibition may be because it reflects only one exercise bout. 
In cases where exercise is repeated multiple times each week 
over an extended period, the exercise-induced serological fac-
tors have multiple opportunities to interact with dysplastic or 
cancerous cells, culminating in a more pronounced suppres-
sion of cellular growth (Dethlefsen, Pedersen, et al., 2017; 
Hojman et  al.,  2018). This suggests that being physically 
active on several days per week, rather than accumulating 
all weekly activity across one or two days per week, may be 
particularly important for reducing cancer risk. While specu-
lative, this proposition aligns with current physical activity 
guidance recommending that adults are physically active 
every day to elicit optimal health benefits (Physical Activity 
Guidelines Advisory Committee Scientific Report,  2018; 
World Cancer Research Fund/American Institute for Cancer 
Research, 2018b).
Six included studies evaluated exercise-induced changes 
in serological biomarkers in attempts to identify which 
physiological factors were associated with changes in can-
cer cell growth (Baldelli et  al.,  2020; Dethlefsen, Hansen, 
et al., 2017; Dethlefsen et al., 2016; Devin et al., 2019; Hwang 
et al., 2020; Kurgan et al., 2017). Serum epinephrine, norepi-
nephrine, pro-inflammatory cytokines (TNF-α), and myok-
ines (IL-6, IL-8, osteonectin, oncostatin M) were reported 
to significantly increase following acute bouts of exercise 
(Dethlefsen, Hansen, et  al.,  2017; Dethlefsen et  al.,  2016; 
Devin et al., 2019; Hwang et al., 2020). While the underly-
ing mechanistic pathways linking these serological factors to 
reduced cancer progression are not fully understood, there is 
accumulating evidence that IL-6 release from skeletal muscle 
during exercise may play an important role, either directly or 
indirectly through the induction of anti-inflammatory cyto-
kines such as IL-1 receptor antagonist (IL-1ra) (Christensen 
et  al.,  2018; Petersen & Pedersen,  2005). During exercise, 
IL-6 signaling stimulates the release of IL-1ra from macro-
phages and monocytes, leading to elevated levels in serum 
(Gleeson et  al.,  2011; Steensberg et  al.,  2003). IL-1ra 
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competitively blocks the pro-inflammatory actions of IL-1α 
and IL-1β at the receptor level, which have been implicated in 
tumor growth (Apte et al., 2006). However, while IL-1ra ad-
ministration has been shown to inhibit tumor growth in vivo, 
several studies have failed to show an effect of IL-1ra treat-
ment on proliferation rates in vitro (Elaraj et al., 2006; Lewis 
et al., 2006; Triozzi et al., 2011).
Administration of IL-6 and oncostatin M has been shown 
to suppress breast cancer growth in vitro (Chiu et al., 1996; 
Hojman et al., 2011), suggesting that IL-6 and other myok-
ines could have a direct role in reducing cancer progression 
by modulating key signaling pathways involved in cancer cell 
proliferation. For instance, murine studies show that aerobic 
exercise regulates the Protein Kinase B/mammalian target 
of rapamycin (AKT/mTOR) signaling pathway (Thompson 
et al., 2009) which is a key cell growth regulator and is hy-
peractivated in many cancer types (Porta et al., 2014). While 
the exact mechanisms underlying the exercise-dependent de-
activation of AKT/mTOR signaling have not been fully elu-
cidated, IL-6 is a potential candidate because of its effects 
on AMP-activated protein kinase (AMPK) signaling. IL-6 re-
lease from skeletal muscle during exercise is known to activate 
AMPK (MacDonald et al., 2003), which can inhibit mTOR 
and its downstream effectors such as ribosomal protein S6 
kinase beta-1 (S6K1) through a Tuberous Sclerosis Complex 
2 (TSC2)-dependent or -independent mechanism (Bolster 
et  al.,  2002; Kawaguchi et  al.,  2015). Kurgan et  al.  (2017) 
showed that incubating A549 nonsmall cell lung cancer cells 
with exercise-conditioned serum reduced cell growth and 
decreased the phosphorylation levels of AKT, mTOR, and 
S6K1. However, exercise-conditioned serum did not influ-
ence the growth of MRC5 normal lung fibroblasts (Kurgan 
et al., 2017), suggesting that the effect of exercise serum may 
be specific to malignant cells that harbor aberrant activation 
of signaling pathways. Interestingly, incubation with serum 
collected 24-hr after exercise cessation also reduced A459 
cell growth and inhibited the activation of these signaling 
molecules (Kurgan et  al.,  2017). It is well recognized that 
most serum markers elevated during acute exercise, includ-
ing IL-6 and other myokines, return to basal levels within 
24 hr of exercise cessation (Cerqueira et al., 2019). Thus, it 
is unclear whether IL-6 directly contributed to the prolonged 
inhibition of the AKT/mTOR signaling pathway in this study, 
or whether downstream priming effects were involved.
Dethlefsen, Hansen, et al. (2017) also showed that serum 
obtained after combined resistance and aerobic interval exer-
cise activated the Hippo signaling pathway, which involves 
a kinase cascade from the tumor suppressors mammalian 
Mst1 and Mst2 to the oncoproteins Yes-associated protein 
(YAP) and transcriptional coactivator with PDZ-binding 
motif (TAZ) (Pan,  2010). Stimulating MCF-7 cells with 
postexercise serum induced the phosphorylation and subse-
quent cytosolic sequestration of YAP, which was associated 
with a reduced expression of genes downstream of YAP 
(e.g., ANKRD1) (Dethlefsen, Hansen, et  al.,  2017). Direct 
stimulation of breast cancer cells with epinephrine/norepi-
nephrine mimicked this effect and combining participant 
serum with a β-adrenergic blocker (propranolol) decreased 
the phosphorylation of YAP, suggesting adrenergic signaling 
was responsible for the exercise-induced suppression of can-
cer cell growth (Dethlefsen, Hansen, et al., 2017). However, 
the same study showed no significant effect of exercise-con-
ditioned serum on total or phosphorylated levels of YAP in 
MDA-MB-231 cells (Dethlefsen, Hansen, et al., 2017). More 
recently, Baldelli et  al.  (2020) also showed no significant 
effect of serum collected immediately postexercise on YAP 
phosphorylation in MDA-MB-231 or LNCaP cells. Taken to-
gether, it is uncertain from the current evidence whether the 
ability of exercise to modulate downstream effectors of the 
Hippo signaling pathway contributes to the antimitotic effect 
of exercise.
There were concerns regarding the risk of bias within in-
dividual studies. Common issues included unclear fidelity 
to the exercise protocol, a lack of assessor blinding, and in-
adequate control of potentially confounding variables such 
as diet and physical activity prior to the experimental ses-
sion. Inadequate control of diet may affect the serological 
response to exercise. For example, depletion of intramuscu-
lar glycogen stimulates enhanced release of muscle-derived 
IL-6 (Fischer,  2006) and therefore consuming a high car-
bohydrate meal prior to exercise may attenuate IL-6 release 
compared with a lower carbohydrate meal. Dietary bioactive 
compounds and antioxidant capacity may also influence se-
rum-stimulated cancer cell growth (Fleshner et  al.,  1999; 
Tymchuk et  al.,  2001). Furthermore, despite that our eligi-
bility criteria only required studies to have obtained a blood 
sample before and immediately after an acute exercise bout, 
no included study attempted to control for measurement error 
and/or normal biological variability in serum markers by em-
ploying a randomized, controlled, crossover study design. 
Indeed, plasma cytokine concentrations (IL-6 and IL-10) 
have been shown to increase from pre to postexercise, but this 
increase was not significantly different from a nonexercise 
control (Windsor et  al., 2018), highlighting the importance 
of including a control condition. As well as bias within indi-
vidual studies, Egger's test of the intercept and visual inspec-
tion of the funnel plot were suggestive of small-study effects, 
which may indicate publication and/or reporting bias, among 
other issues (Page et al., 2020). Thus, these potential biases 
should be considered when interpreting the findings of this 
meta-analysis, and further trials using more rigorous experi-
mental designs are warranted.
There was evidence of considerable heterogeneity be-
tween studies. The inclusion of study characteristics as co-
variates in the meta-analytic model, including participant age 
and disease status, exercise type, cancer type, cell line TP53 
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status, and serum incubation time, had a negligible influence 
on the magnitude of heterogeneity or the pooled treatment 
effect. However, it is unlikely that the number of trials in-
cluded in the meta-regressions was sufficient to provide ad-
equate statistical power to detect moderating effects, and the 
results should be treated with caution. Because differences 
in subgroups observed within studies are more reliable than 
analyses of subsets of studies (Deeks et al., 2019), further re-
search should directly evaluate whether the antimitotic effect 
of exercise is modified by these factors. For instance, given 
the important role of intensity on the serological response to 
exercise (Fischer,  2006; Zouhal et  al.,  2008) a direct com-
parison of the effects of work-matched moderate- versus 
high-intensity aerobic exercise on serum-stimulated cancer 
cell growth is warranted. Hwang et  al.  (2020) did show a 
statistical reduction in LNCaP cell growth in older but not 
younger adults following stimulation with postexercise com-
pared with preexercise serum, suggesting a modifying effect 
of age. However, the magnitude of effects was not directly 
compared between the two subgroups, which is required for 
valid inference (Deeks et al., 2019; Gelman & Stern, 2006).
A limitation of all studies included in this review is the 
use of two-dimension (2D) cell culture models, which do not 
fully mimic the in vivo tumor morphology or microenviron-
ment. Another drawback to cells growing in a 2D monolayer 
is the unlimited access to essential compounds in the culture 
medium such as oxygen, nutrients, and serum (Kapałczyńska 
et al., 2018). This is in contrast to cancer cells in vivo, which 
have variable access to oxygen and nutrients due to the ar-
chitecture of the tumor mass (Kapałczyńska et  al.,  2018). 
Three-dimensional (3D) cell cultures better recapitulate in 
vivo tumor physiology and the physical characterizes of a 
solid tumor mass (Duval et al., 2017). Two studies included 
in this review used 3D cell culture techniques to show that 
exercise-conditioned serum reduces the clonogenic poten-
tial of breast (Baldelli et al., 2020; De Santi et al., 2019) and 
prostate (Baldelli et al., 2020) cancer cells. Future research 
should consider using 3D cell culture models, such as pa-
tient-derived tumor spheroids, to better reflect in vivo tumor 
conditions and provide stronger evidence on the effect of 
acute exercise on cancer cell growth. Future studies should 
also consider controlling for hydration status because hypo-
hydration may increase serum protein concentration, which 
could impact serum-stimulated cell growth.
It is worth noting that we limited our review to studies 
that collected serum within 5  min of acute exercise cessa-
tion. This was to standardized the timepoint at which sera 
was sampled because this can have a substantial effect on the 
serological response (Brooks et al., 1990), and to ensure we 
did not include studies that characterized serological changes 
in response to a chronic exercise intervention (as opposed 
to acute exercise). Nevertheless, some studies have shown 
that serum collected up to 24 hr postacute exercise inhibits 
cancer cell growth (Baldelli et al., 2020; Kurgan et al., 2017; 
Rundqvist et  al.,  2013), suggesting that the serological re-
sponse to acute exercise may have growth inhibitory effects 
for several hours after exercise cessation.
In conclusion, we showed that exercise-conditioned serum 
significantly reduces in vitro cancer cell growth. This finding 
provides preliminary evidence that acute exercise-induced 
modulations in serum markers may, at least in part, explain 
the link between regular physical activity and reduced cancer 
risk. Many questions still remain regarding the underlying 
mechanistic pathways and potential effect modifiers such as 
exercise intensity and cancer cell phenotype. To strengthen 
this evidence-base, future studies should seek to reduce the 
risk of bias by using more rigorous experimental designs and 
consider using 3D cell culture models to better replicate in 
vivo tumor conditions.
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